Lisandra Silva created an Instagram account saying her “Ozempic” is “healthy lifestyle”; Medical bodies have already warned about the use of drugs, created to treat diabetes, for weight loss. Novo Nordisk, the pharmaceutical company responsible, has not yet commented
Cuban actress Lisandra Silva37 years old, made a report on Instagram stating that she had to be rushed to hospital after use Ozempico to try to lose weight. Medical bodies have already warned about the use of the drug, created to treat uncontrolled type 2 diabetes but used indiscriminately for weight loss.. Lisandra reported the case last Friday 1.
THE Estadao has contacted Novo Nordisk, the pharmaceutical company responsible for Ozempic, to comment on the actress’ publication, but has not yet received a response. The space remains open.
Lisandra said, in a long text published on the social network, that the medicine had been recommended to her by a doctor. She, however, had to be admitted to hospital after suffering a drop in her blood sugar level.
“I had to call the children’s father when I felt like I was fainting and my children were sleeping next to me,” she said. “Thank God nothing happened, but I felt like I was dying and I arrived at the clinic in a wheelchair.”
The actress said her “Ozempic” is “Ayurvedic diet, meditation and exercise in nature.” “Discipline, determination, mental strength and clear goals. Health of mind, body and heart. Please listen to my advice. Nothing like a healthy lifestyle. Don’t make it up,” he asked his followers.
Doctors warn against using Ozempic for weight loss
Last year, the Brazilian Association for the Study of Obesity (ABESO) and the Brazilian Society of Endocrinology and Metabology (SBEM) published a joint note on the use of the drug with “guidelines for the population”. Through the statement, medical bodies make it clear that obesity is a chronic, complex, multi-cause and difficult to treat disease. Therefore, no drug should be used without a prescription and medical supervision.
Ozempic is the trade name of the medicine whose active ingredient is semaglutide. In combination with diet and exercise, the drug is used to treat adult patients with inadequately controlled type 2 diabetes (when blood sugar remains too high), according to Novo Nordisk. Read the full note:
“- Anti-obesity drugs approved by Anvisa have proven their effectiveness and safety and should not be condemned, but rather individually selected within the framework of a medical consultation and sold only on prescription. It is the task of the prescribing doctor to monitor the patient and periodically reevaluate their effectiveness, tolerability and safety.
– The improper, aesthetic or inappropriate use of anti-obesity drugs, in addition to exposing people to risks without indication of use, increases the stigma of treatment for those who already suffer from various prejudices in our society. Issues that worsen this stigma can lead people to abandon effective treatments or avoid seeking medical care.
– In addition, we remind you that ABESO and SBEM seek to improve access to obesity treatments for the general population, both by working to reduce prejudices against obesity therapies (pharmacological or otherwise), and by seeking, together with the authorities public, to have therapeutic options accessible to the majority of the population, or made available by SUS, which is not yet a reality.”
The declaration was signed by Bruno Halpern, president of ABESO, and Paulo Augusto Carvalho Miranda, president of SBEM.

Source: Terra

Rose James is a Gossipify movie and series reviewer known for her in-depth analysis and unique perspective on the latest releases. With a background in film studies, she provides engaging and informative reviews, and keeps readers up to date with industry trends and emerging talents.